Contact this trialFirst, we need to learn more about you.
Aromatase Inhibitor
Letrozole for Breast Cancer
Recruiting3 awardsPhase 2
Jacksonville, Florida
This trial looks at letrozole as a treatment for operable hormone receptor positive, HER2 negative breast cancer. Letrozole is an aromatase inhibitor, which works by decreasing the amount of estrogen produced by the body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.